Sep
28
2021
On demand

GMP manufacturing for exosome-based therapies: the critical role of analytics and process design for clinical production and scale-up

When producing exosomes-based therapies, analytics and process design are key to build a successful manufacturing process that keeps you in control of your product for clinical and beyond. There is a fine balance to find, in order to measure appropriately the critical quality attributes of your product, without over-complicating an already complex validation process. During this webinar, our experts will propose a roadmap for EV analytics and process design.

  • Extracellular vesicle biology as new drug modality
  • Analytics for process design and definition of exosome drug substance
  • Manufacturing of exosomes, challenges and opportunities
  • How to establish an effective process for clinical manufacturing and beyond

Marcos Langtry

Head of Allogeneic Cell Therapy Commercial Development, Lonza Pharma & Biotech

Marcos Langtry is Head of Allogeneic Cell Therapy Commercial Development at Lonza Pharma & Biotech. He is responsible for the allogeneic commercial strategy, current and future offerings, and portfolio optimization. Before joining Lonza, Marcos held several senior level positions at TiGenix, Astra Zeneca and Sanofi in the areas of external manufacturing, process development, technical operations and industrial strategy; where he acquired extensive experience with aseptically filled, biologic and cell therapy products.

Marcos Langtry holds a Master´s degree in Biochemical Engineering from University College London (UK) and an MBA from Imperial College London (UK). He is also qualified as Chartered Engineer (CEng) and Chartered Scientist (CSci).

Davide Zocco

Research & Development Senior Manager, Lonza Pharma & Biotech

Davide Zocco has joined Lonza (2020) as senior manager to lead R&D projects for the manufacturing of extracellular vesicles (VEs) within Cell and Gene Therapy Business Unit. He holds the position of Chief Technology Officer at his former company, Exosomics, a Lonza’s strategic R&D partner, to foster the development of protocols and kits for the isolation and characterization of EVs from body fluids. He is author of peer-reviewed publications in high profile journals, including Nature Chemical Biology, PNAS and American Journal of Pathology (>2000 citations), and of three patents in the extracellular vesicle field. He holds a PhD from University College Dublin (Ireland) and he was a postdoctoral research fellow at Harvard Medical School (USA).

SPEAKERS

Marcos Langtry
Head of Allogeneic Cell Therapy Commercial Development, Lonza Pharma & Biotech
Davide Zocco
Research & Development Senior Manager, Lonza Pharma & Biotech

You might also like

Thinking translational: Things to consider in CAR T cell research workflows

S Rösch, PhD
Saskia Rösch, PhD
Saskia Rösch, PhD
Global Product Manager at Miltenyi Biotec
22 Jun 2022
34
Days
23
Hrs
6
Min
Register

Optimizing mRNA purification conditions by using a Design of Experiments...

J England
Jenny England
Jenny England
Application Scientist and Innovation Leader at Thermo Fisher Scientific
14 Jun 2022
26
Days
23
Hrs
6
Min
Register

Monitoring of circulating CAR T cells

A Graband,
D Hünecke,
D Bremm
Annika Graband
Annika Graband
Product Manager, Cell Analysis Reagents at Miltenyi Biotec
Dr. Sabine Hünecke
Dr. Sabine Hünecke
Head of Laboratory, Stem Cell Transplantation and Immunotherapy at University Hospital Frankfurt
Dr. Melanie Bremm
Dr. Melanie Bremm
Deputy Head of Laboratory, Stem Cell Transplantation and Immunotherapy at University Hospital Frankfurt
31 May 2022
12
Days
23
Hrs
6
Min
Register

Improving T cell therapy manufacturing processes with automation and...

E Zynda, PhD
Evan Zynda, PhD
Evan Zynda, PhD
Staff Scientist, Cell Biology at Thermo Fisher Scientific
26 May 2022
7
Days
23
Hrs
6
Min
Register

Streamlined workflow solutions for cell and gene therapy analytics

A Graband
Annika Graband
Annika Graband
Product Manager, Cell Analysis Reagents at Miltenyi Biotec
24 May 2022
5
Days
23
Hrs
6
Min
Register